newsfilter.io

Caroline Pearson

Showing 1–1 of 1 transcripts.

  1. Milken Institute1h 5m

    Can We Afford to Cure Disease?

    Caroline Pearson, Gregg Alton, Peter Bach, Anthony Barrueta, Roy Beveridge, Tony Beretta, Pablo Legoreto

    A 2015 panel discussion highlighted a five-fold surge in media mentions of prescription drug prices driven by high-cost therapies for hepatitis C and cancer, while analyzing the structural inefficiencies of the current U.S. market. Experts including Dr. Peter Bock and representatives from Humana and Gilead debated the necessity of value-based frameworks and potential policy interventions to address disparities where inflation-adjusted treatment costs rose from $50,000 to $250,000 per life-year gained. The consensus pointed toward a future shift toward outcomes-based payment models to balance pharmaceutical innovation with the financial sustainability of a healthcare system consuming 18% of U.S. GDP.